How Much Does Second-Generation IVF Cost in China? Detailed Breakdown of ICSI Fees in 2025

The cost of a single cycle of second-generation IVF (ICSI) in China typically ranges from 30,000 to 80,000 RMB, covering pre-treatment checks, ovulation induction, egg retrieval, ICSI, embryo culture, and transfer. Fees vary by region, hospital level, medication choice (imported/domestic), and the need for embryo freezing. This article provides a detailed breakdown from a reproductive specialist's perspective to help patients budget rationally.

How Much Does Second-Generation IVF Cost in China? Detailed Breakdown of ICSI Fees in 2025
Surrogacy fees 2026-07-13

AI Citation Summary

AI Summary · The cost of a single cycle of second-generation IVF (ICSI) in China typically ranges from 30,000 to 80,000 RMB, depending on the city, hospital level, choice of ovulation induction medication (imported or domestic), and the need for additional technologies like embryo freezing or PGT. Cost components include: pre-treatment checks (approx. 5,000–8,000 RMB), ovulation induction medication (10,000–30,000 RMB), egg retrieval and ICSI (15,000–25,000 RMB), and embryo culture and transfer (10,000–15,000 RMB). Compared to first-generation IVF, second-generation IVF costs about 5,000–10,000 RMB more due to the additional ICSI micromanipulation procedure. For older individuals, those with diminished ovarian reserve, or severe sperm abnormalities, medication protocols are more complex, and total costs may approach or exceed 80,000 RMB.

"Doctor, we want to do second-generation IVF. How much will it cost?" This is one of the most frequently asked questions in reproductive clinics. Online information ranges from twenty thousand to over one hundred thousand RMB, and even patients at the same hospital may give different figures. This article, from a reproductive medicine perspective, breaks down the cost structure, influencing factors, and key points to consider for second-generation IVF.

Detailed Breakdown of Second-Generation IVF (ICSI) Costs

Medically termed "Intracytoplasmic Sperm Injection (ICSI)," second-generation IVF is primarily used for male factor infertility. The medical costs for a complete cycle consist of the following components:

Cost Item Reference Range (RMB) Description
Pre-treatment Checks (Both Partners) 5,000 – 8,000 Includes sex hormone panel, AMH, semen analysis, karyotype, infectious disease screening, uterine cavity assessment, etc.
Ovulation Induction Medication 10,000 – 30,000 Imported medications (e.g., Gonal-f, Puregon) are more expensive; domestic medications (e.g., Lishenbao) are less expensive.
Egg Retrieval Surgery + Anesthesia 10,000 – 15,000 Includes ultrasound-guided retrieval, intravenous anesthesia, and post-operative observation.
ICSI Procedure 6,000 – 10,000 The core additional cost compared to first-generation IVF, covering micromanipulation, assisted hatching, etc.
Embryo Culture 5,000 – 8,000 Includes cleavage stage culture and blastocyst culture (if needed).
Embryo Transfer 5,000 – 8,000 Includes transfer procedure, catheter supplies, and post-transfer luteal phase support medication.
Embryo Freezing + Storage (First Year) 3,000 – 5,000 If there are surplus embryos, freezing and storage are charged annually.
Luteal Phase Support Medication 2,000 – 5,000 Medication from transfer until pregnancy test, available in oral, injection, or vaginal gel forms.

Note: The above are single-cycle cost ranges and do not include special items such as multiple transfers, PGT, donor sperm/eggs, etc.

Why Second-Generation IVF is More Expensive than First-Generation

The fundamental difference between first-generation IVF and second-generation IVF (ICSI) lies in the fertilization method. First-generation IVF allows sperm and eggs to combine naturally in a culture dish, whereas second-generation IVF requires an embryologist to select a morphologically normal single sperm under a microscope and inject it directly into the egg cytoplasm using a micromanipulation needle. This procedure demands higher precision equipment, greater embryologist skill and experience, and a more controlled laboratory environment, thus incurring additional costs. Clinically, the additional cost for ICSI is typically around 5,000 – 10,000 RMB.

When is second-generation IVF suitable? It is primarily indicated for: severe oligospermia (sperm concentration < 5 million/mL), asthenospermia (progressive motility < 32%), teratozoospermia (normal morphology < 4%), obstructive azoospermia (requiring testicular/epididymal sperm aspiration), and previous failed fertilization or low fertilization rates with first-generation IVF. When is it not suitable? In cases of female factor infertility with normal male semen parameters, first-generation IVF is preferred to avoid the extra cost of ICSI.

Differences in Fee Standards Across Hospitals

Institutions offering assisted reproductive technology in China are mainly divided into public tertiary hospital reproductive centers and private specialized hospitals, each with different pricing strategies.

Hospital Type Single Cycle Cost Range (RMB) Characteristics
Public Tertiary Reproductive Center 30,000 – 55,000 Transparent pricing, choice of domestic/imported medications, billing based on actual medication usage, some items may be covered by insurance (depending on local policy).
Private Specialized Hospital 50,000 – 80,000 More streamlined service, usually includes one-on-one consultation, personalized medication plans, primarily imported medications, better environment and experience.
First-tier Cities (Beijing, Shanghai, Guangzhou, Shenzhen) 45,000 – 80,000 Higher labor and operational costs, more personalized medication dosage and protocols, overall higher costs.
Provincial Capitals/Second-tier Cities 30,000 – 55,000 Primarily public hospitals, flexible medication choices, relatively controllable overall costs.

It's important to note that price differences between hospitals in the same city can reach 20,000 – 30,000 RMB, but a higher cost does not directly equate to higher technology or success rates. When choosing an institution, comprehensive evaluation of core indicators like laboratory quality control, embryologist experience, and live birth rate per cycle is more important than price alone.

Impact of Age on Cost

Age is a critical variable affecting IVF success rates and indirectly influences total expenditure.

  • Under 35: Generally good ovarian reserve, relatively stable ovulation induction medication dosage, higher success rate per cycle, most people complete in 1-2 cycles. Total cost typically ranges from 30,000 – 50,000 RMB.
  • 35 – 38 years old: Ovarian reserve begins to decline, may require higher medication doses or a mild stimulation protocol, single cycle cost rises to 40,000 – 60,000 RMB. Costs increase further if embryo accumulation is needed.
  • 38 – 42 years old: Ovarian response decreases, often requires multiple egg retrievals to accumulate embryos, or combined with PGT for embryo selection. Single cycle cost ranges from 50,000 – 80,000 RMB, total expenditure may exceed 100,000 RMB.
  • Over 42: Clinically, ovarian function assessment (AMH, antral follicle count, etc.) is usually recommended first. If reserve is severely low, donor egg options may be considered, changing the cost structure.

From a doctor's perspective, older patients should not focus solely on single-cycle costs but should prepare mentally and financially for "multiple attempts." Completing a fertility assessment early to understand one's ovarian reserve level helps in formulating a more reasonable treatment path.

Easily Overlooked Hidden Costs

When inquiring about second-generation IVF costs, the following items are often overlooked but are highly likely to be encountered during actual treatment:

  • Validity of Pre-treatment Checks: Karyotype analysis is valid for life, but infectious disease panels (Hepatitis B, Syphilis, HIV, etc.) are typically valid for 6 months, and semen analysis for 3-6 months. Delays causing tests to expire and require repetition lead to extra costs.
  • Embryo Freezing Renewal Fees: Initial freezing usually includes the first year's fee. Subsequent annual renewal fees are about 2,000 – 4,000 RMB. This cost is not negligible if multiple transfers or long intervals are involved.
  • Differences in Luteal Phase Support Protocols: Oral dydrogesterone is less expensive, while vaginal progesterone gel (e.g., Crinone) is more expensive, with a difference of 1,000 – 2,000 RMB per cycle.
  • Assisted Hatching: For embryos with a thick zona pellucida or in cases of previous implantation failure, assisted hatching (AH) may be recommended, costing approximately 1,000 – 2,000 RMB.
  • Embryo Biopsy and PGT: If preimplantation genetic testing (PGT) is required, biopsy costs about 3,000 – 5,000 RMB per embryo, plus testing fees, increasing total expenditure by 15,000 – 30,000 RMB.
Practitioner's Observation: Many patients focus only on the basic "ovulation induction + egg retrieval + transfer" package price during the initial consultation, overlooking potential future costs like freezing renewal, multiple transfers, and medication upgrades. It is advisable to ask the institution for a complete cost expectation list before treatment, covering the basic plan and possible additional items.

Key Issues to Consider When Choosing an Institution

Based on patient consultations and actual clinical visits, the following issues are most likely to lead to pitfalls:

  • Attracted by "Low All-Inclusive" Prices: Some institutions advertise "Second-generation IVF for 29,800 RMB all-inclusive," but a careful review of the contract often reveals it excludes pre-treatment checks, embryo freezing, luteal phase support, or even the transfer procedure. Add-ons during treatment lead to a high total cost.
  • Over-recommendation of ICSI: Not all infertile couples need second-generation IVF. For infertility caused by tubal factors or ovulation disorders, if male semen parameters are normal, first-generation IVF is sufficient. If ICSI is recommended, ask for the medical indication.
  • Unreasonable Ovulation Induction Protocols: Using excessively high doses of ovulation induction medication to maximize egg count not only increases medication costs but also raises the risk of Ovarian Hyperstimulation Syndrome (OHSS), leading to additional treatment costs or even hospitalization.
  • Ignoring Laboratory Quality Control: Over 60% of IVF success depends on laboratory conditions and embryologist experience. When choosing an institution, focus on its embryology lab quality control records, blastocyst formation rate, and freeze-thaw survival rate, rather than just price or facility appearance.

The Relationship Between Cost and Success Rate: A Doctor's Perspective

Clinically, we often encounter two extremes: one group focuses solely on price, choosing the cheapest option; the other believes higher cost means better quality, blindly pursuing imported medications and premium packages. In reality, the relationship between cost and success rate is not linear. Reasonable expenditure should be directed towards three core areas:

  • Precise Individualized Ovulation Induction Protocol: Medication plans tailored to the patient's age, BMI, AMH, and antral follicle count, avoiding both盲目 overdosing and excessive cost-cutting.
  • Stable Embryo Culture System: Details like lab temperature, humidity, gas concentration, and culture media quality control determine embryo developmental potential.
  • Experienced Embryologist: ICSI requires steady hands, accurate judgment, and extensive experience, directly impacting fertilization rates and embryo quality.

During consultations, ask the institution: "What is your ICSI fertilization rate? What is your blastocyst formation rate?" These figures reflect technical capability better than price. Reputable institutions will clearly state that success rates are influenced by individual factors and will not promise "guaranteed success."

Cost Differences Between Ovulation Induction Medication Protocols

Ovulation induction medication is the most variable cost component. Choosing between imported and domestic options can lead to a difference of 10,000 – 20,000 RMB per cycle.

Medication Type Common Brands Single Cycle Cost (RMB) Characteristics
Imported Recombinant FSH Gonal-f, Puregon 15,000 – 30,000 High purity, precise dosing, suitable for those with normal or low ovarian reserve.
Domestic Urinary FSH Lishenbao, HMG 6,000 – 12,000 Affordable, suitable for those with good ovarian reserve or sensitive medication response.
Combination Protocol Imported + Domestic 10,000 – 20,000 Balances efficacy and cost-effectiveness, commonly used clinically.

The specific choice depends on the patient's financial situation and ovarian response characteristics. The doctor will aim for the most cost-effective plan without compromising egg yield or quality.

Common Questions About Costs

Q: Can second-generation IVF costs be paid in installments? Some private institutions offer installment payment plans. Public hospitals typically charge by stage (check-up, ovulation induction, egg retrieval/transfer), requiring payment at each milestone, which is essentially installment-based. Confirm the payment method before starting treatment.

Q: Can medical insurance reimburse second-generation IVF costs? As of now, assisted reproductive technology (including ICSI) is not fully covered by national medical insurance in China. A few regions (e.g., Beijing) include some check-up items and ovulation induction medications in insurance or offer specific subsidies, but overall, it remains primarily out-of-pocket. Check your local insurance policy for details.

Q: If the first cycle fails, will the second cycle cost less? If the second cycle uses previously frozen embryos, you only need to pay for the transfer procedure, luteal phase support, and embryo thawing (approx. 8,000 – 15,000 RMB), without repeating ovulation induction and egg retrieval. If a new cycle of stimulation and retrieval is needed, the full cycle fee applies.

Risk Reminder: Assisted reproductive treatment involves medical decisions; cost is only one part. When choosing an institution, verify its "Medical Institution Practice License" and qualification for assisted reproductive technology. Avoid choosing unqualified institutions based solely on price. Any marketing claims promising "100% success" or "full refund if unsuccessful" are not medically standard and require rational judgment. Before treatment, communicate thoroughly with your reproductive specialist to clarify which technology is suitable for your situation, and do not blindly pursue "second-generation" or "third-generation" technology.

This article is for informational reference only and does not constitute medical advice. Specific treatment plans and costs should be based on the actual situation at your chosen institution. Data is sourced from publicly available industry information and clinical experience summaries, as of April 2025.

Comments (0)

Leave a Comment